Description
Improper authorization in Azure allows an authorized attacker to elevate privileges over a network.
Published: 2025-04-30
Score: 9.9 Critical
EPSS: 1.1% Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Remediation

No vendor fix or workaround currently provided.

Additional remediation guidance may be available on OpenCVE Cloud.

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2025-12759 Improper authorization in Azure allows an authorized attacker to elevate privileges over a network.
History

Fri, 13 Feb 2026 20:00:00 +0000

Type Values Removed Values Added
CPEs cpe:2.3:a:microsoft:azure_machine_learning:*:*:*:*:*:*:*:*

Mon, 12 May 2025 20:00:00 +0000

Type Values Removed Values Added
First Time appeared Microsoft
Microsoft azure Machine Learning
Weaknesses NVD-CWE-Other
CPEs cpe:2.3:a:microsoft:azure_machine_learning:-:*:*:*:*:*:*:*
Vendors & Products Microsoft
Microsoft azure Machine Learning

Wed, 30 Apr 2025 18:15:00 +0000

Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'no', 'Exploitation': 'none', 'Technical Impact': 'total'}, 'version': '2.0.3'}


Wed, 30 Apr 2025 17:30:00 +0000

Type Values Removed Values Added
Description Improper authorization in Azure allows an authorized attacker to elevate privileges over a network.
Title Azure ML Compute Elevation of Privilege Vulnerability
Weaknesses CWE-285
References
Metrics cvssV3_1

{'score': 9.9, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H/E:U/RL:O/RC:C'}


Subscriptions

Microsoft Azure Machine Learning
cve-icon MITRE

Status: PUBLISHED

Assigner: microsoft

Published:

Updated: 2026-02-26T18:29:05.876Z

Reserved: 2025-03-21T19:09:29.815Z

Link: CVE-2025-30390

cve-icon Vulnrichment

Updated: 2025-04-30T17:25:02.929Z

cve-icon NVD

Status : Analyzed

Published: 2025-04-30T18:15:46.493

Modified: 2025-05-12T19:43:00.560

Link: CVE-2025-30390

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses